These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 27372848)

  • 1. Use of Escherichia coli Nissle 1917 producing recombinant colicins for treatment of IBD patients.
    Kotłowski R
    Med Hypotheses; 2016 Aug; 93():8-10. PubMed ID: 27372848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammation-associated adherent-invasive Escherichia coli are enriched in pathways for use of propanediol and iron and M-cell translocation.
    Dogan B; Suzuki H; Herlekar D; Sartor RB; Campbell BJ; Roberts CL; Stewart K; Scherl EJ; Araz Y; Bitar PP; Lefébure T; Chandler B; Schukken YH; Stanhope MJ; Simpson KW
    Inflamm Bowel Dis; 2014 Nov; 20(11):1919-32. PubMed ID: 25230163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of Species-specific Antibiotics Against Crohn's Disease-Associated Adherent-invasive Escherichia coli.
    Brown CL; Smith K; Wall DM; Walker D
    Inflamm Bowel Dis; 2015 Oct; 21(10):2372-82. PubMed ID: 26177305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Crohn disease, ulcerative colitis. When bacteria attack the intestinal wall....].
    Duchmann R; Lochs H; Kruis W
    MMW Fortschr Med; 1999 Dec; 141(51-52):48-51. PubMed ID: 10949626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monocyte-derived macrophages from Crohn's disease patients are impaired in the ability to control intracellular adherent-invasive Escherichia coli and exhibit disordered cytokine secretion profile.
    Vazeille E; Buisson A; Bringer MA; Goutte M; Ouchchane L; Hugot JP; de Vallée A; Barnich N; Bommelaer G; Darfeuille-Michaud A
    J Crohns Colitis; 2015 May; 9(5):410-20. PubMed ID: 25805890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of the pathobiont adherent-invasive Escherichia coli and inflammatory bowel disease: a systematic review and meta-analysis.
    Nadalian B; Yadegar A; Houri H; Olfatifar M; Shahrokh S; Asadzadeh Aghdaei H; Suzuki H; Zali MR
    J Gastroenterol Hepatol; 2021 Apr; 36(4):852-863. PubMed ID: 32929762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High prevalence of aggregative adherent Escherichia coli strains in the mucosa-associated microbiota of patients with inflammatory bowel diseases.
    Thomazini CM; Samegima DA; Rodrigues MA; Victoria CR; Rodrigues J
    Int J Med Microbiol; 2011 Aug; 301(6):475-9. PubMed ID: 21616711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adherent-Invasive E. coli enhances colonic hypersensitivity and P2X receptors expression during post-infectious period.
    Lashermes A; Boudieu L; Barbier J; Sion B; Gelot A; Barnich N; Ardid D; Carvalho FA
    Gut Microbes; 2018 Jan; 9(1):26-37. PubMed ID: 28806140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Invasive Escherichia coli are a feature of Crohn's disease.
    Sasaki M; Sitaraman SV; Babbin BA; Gerner-Smidt P; Ribot EM; Garrett N; Alpern JA; Akyildiz A; Theiss AL; Nusrat A; Klapproth JM
    Lab Invest; 2007 Oct; 87(10):1042-54. PubMed ID: 17660846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adherent-invasive Escherichia coli: a putative new E. coli pathotype associated with Crohn's disease.
    Darfeuille-Michaud A
    Int J Med Microbiol; 2002 Sep; 292(3-4):185-93. PubMed ID: 12398209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Escherichia coli isolates from patients with inflammatory bowel disease: ExPEC virulence- and colicin-determinants are more frequent compared to healthy controls.
    Micenková L; Frankovičová L; Jaborníková I; Bosák J; Dítě P; Šmarda J; Vrba M; Ševčíková A; Kmeťová M; Šmajs D
    Int J Med Microbiol; 2018 Jul; 308(5):498-504. PubMed ID: 29735381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Colicinogens in nonspecific intestinal inflammation. I. Colicinotypes in patients with ulcerous colitis, Crohn's disease and in healthy individuals].
    Bures J; Horák V; Buresová E; Fixa B; Komárková O
    Cesk Gastroenterol Vyz; 1983 Mar; 37(2):81-6. PubMed ID: 6342822
    [No Abstract]   [Full Text] [Related]  

  • 13. Microbial-host interactions in inflammatory bowel diseases and experimental colitis.
    Sartor RB
    Nestle Nutr Workshop Ser Pediatr Program; 2009; 64():121-32; discussion 132-7, 251-7. PubMed ID: 19710519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effect of probiotic Escherichia coli strain Nissle 1917 on adhesion to and invasion of intestinal epithelial cells by adherent-invasive E. coli strains isolated from patients with Crohn's disease.
    Boudeau J; Glasser AL; Julien S; Colombel JF; Darfeuille-Michaud A
    Aliment Pharmacol Ther; 2003 Jul; 18(1):45-56. PubMed ID: 12848625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colicinogeny in chronic inflammatory bowel disease.
    Bures J; Horák V; Buresová E; Fixa B; Komárková O; Hartmann M
    Scand J Gastroenterol; 1986 Sep; 21(7):819-23. PubMed ID: 3535009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. α-Haemolysin of Escherichia coli in IBD: a potentiator of inflammatory activity in the colon.
    Bücker R; Schulz E; Günzel D; Bojarski C; Lee IF; John LJ; Wiegand S; Janßen T; Wieler LH; Dobrindt U; Beutin L; Ewers C; Fromm M; Siegmund B; Troeger H; Schulzke JD
    Gut; 2014 Dec; 63(12):1893-901. PubMed ID: 24534723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ciprofloxacin and probiotic Escherichia coli Nissle add-on treatment in active ulcerative colitis: a double-blind randomized placebo controlled clinical trial.
    Petersen AM; Mirsepasi H; Halkjær SI; Mortensen EM; Nordgaard-Lassen I; Krogfelt KA
    J Crohns Colitis; 2014 Nov; 8(11):1498-505. PubMed ID: 24972748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis of adherent-invasive Escherichia coli.
    Smith EJ; Thompson AP; O'Driscoll A; Clarke DJ
    Future Microbiol; 2013 Oct; 8(10):1289-300. PubMed ID: 24059919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the σE regulon in Crohn's disease-associated Escherichia coli revealed involvement of the waaWVL operon in biofilm formation.
    Chassaing B; Garénaux E; Carriere J; Rolhion N; Guérardel Y; Barnich N; Bonnet R; Darfeuille-Michaud A
    J Bacteriol; 2015 Apr; 197(8):1451-65. PubMed ID: 25666140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum bacterial toxins are related to the progression of inflammatory bowel disease.
    Qiu H; Sun X; Sun M; He C; Li Z; Liu Z
    Scand J Gastroenterol; 2014 Jul; 49(7):826-33. PubMed ID: 24853095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.